Study provides evidence for the "read-across hypothesis". Ibuprofen decreased "prostaglandin E metabolite" (PGEM) levels in fathead minnows. "Mode-of-action" response seen in fish at plasma concentrations similar to the C max . Large inter-individual variation in plasma ibuprofen and PGEM levels observed. 
Introduction
The presence of pharmaceuticals in the aquatic environment, and their real and potential effects on living organisms, have become major research topics. One important issue to resolve is how best to prioritize pharmaceuticals, so that research is focused on those that present the greatest risk to living organisms. Various strategies have been proposed (Roos et al., 2012) . One strategy is to base the ranking of pharmaceuticals on how close the plasma concentrations of wildlife, such as fish, are to the effective drug concentrations in humans, provided that the molecular drug target (i.e. receptor or enzyme) has been conserved: this is the basis of the read-across hypothesis (Huggett et al., 2003; Rand-Weaver et al., 2013; Tanoue et al., 2015) . Currently, little information is available to support the use of the read-across hypothesis to predict the environmental (e.g. river) concentrations of pharmaceuticals that will cause effects to fish. A recent publication (Margiotta-Casaluci et al., 2014) has shown that the anti-depressant fluoxetine affects behavior of fish only when their plasma concentration is within the human therapeutic range. However, the range of fluoxetine concentrations reported to affect various species of aquatic organisms is very wide , suggesting that the read-across hypothesis may not be universally applicable. To assess the robustness of the read-across hypothesis, we investigated the uptake of the human pharmaceutical ibuprofen by fish and the internal (blood plasma) concentrations required to elicit a mode-ofaction related effect.
Ibuprofen is a non-selective inhibitor of the cyclooxygenase (COX) enzyme. There are two mammalian isoforms, COX 1 and COX 2, which are encoded by the ptgs 1 and ptgs 2 genes, respectively. During inflammation, the COX 2 enzyme is rapidly induced, increasing the biosynthesis of prostanoids, primarily prostaglandin E 2 (PGE 2 ). PGE 2 has been identified in teleost fish species (e.g. zebrafish [Danio rerio] (Grosser et al., 2002; Morthorst et al., 2013) ; rainbow trout [Oncorhynchus mykiss] (Knight et al., 1995) and bluntnose minnow [Pimephales notatus] (Bhandari and Venables, 2011) ), suggesting that the human drug target is conserved in fish.
Ibuprofen is a widely prescribed non-steroidal anti-inflammatory drug (NSAID), frequently detected in both wastewater effluents and rivers (Hughes et al., 2013; Osorio et al., 2015) , typically in the low mg/L to ng/L range. There is an increasing body of evidence showing the potential for NSAIDs to perturb physiological processes in aquatic vertebrates, such as cortisol synthesis and osmoregulation (Gravel et al., 2009; Gravel and Vijayan, 2007) , hematological changes (Saravanan et al., 2012) and fish reproduction and development (David and Pancharatna, 2009; Flippin et al., 2007) . Recent studies, investigating possible effects of ibuprofen on fish, have suggested that adverse effects on the reproductive axis occur at concentrations of less than or equal to 0.1 mg/L (Ji et al., 2013) which, if repeatable, would indicate that ibuprofen poses a significant threat to populations of wild fish.
We tested the read-across hypothesis, by determining if ibuprofen inhibits PGE 2 synthesis in fish, mimicking its primary effect in humans, and if so, at what water concentration. Water and plasma concentrations of ibuprofen were measured, as well as gill prostaglandin metabolite levels. By doing so, we assessed the validity of the read-across hypothesis as a means of predicting the water concentration of a pharmaceutical required to induce the anticipated mode-of-action related effect. We also included a water concentration that was not expected to produce the effective plasma concentrations in fish, in order to fully validate the readacross hypothesis.
Materials and methods

Fish husbandry
Adult (4e6 months), all male, fathead minnows were bred and held at AstraZeneca's Brixham Environmental Laboratory (Devon, UK), under a flow-through system at a water temperature of 25 ± 1 C and a 16:8 light/dark photoperiod. Fish were fed (before exposures) twice daily with food pellet (Biomar, Brande, Denmark) and frozen adult brine shrimp (Artemia sp.). Work was conducted under license granted by the UK Home Office under the Animals (Scientific Procedures) Act 1986.
Test chemicals
Ibuprofen (!98% purity, CAS:15687-27-1) was purchased from Sigma-Aldrich (Dorset, UK) and stored at room temperature. Ibuprofen stock solutions were prepared in acetone (CAS No. 67-64-1; !99% purity; Fisher Scientific, Loughborough, UK). Dechlorinated mains water (dilution water) was used to dilute the ibuprofen stock solutions to nominal test concentrations (5, 100, 270, 350, 370 and 500 mg/L) in glass tanks with a working volume of 45 L. A solvent control (SC) was also included. The acetone concentration was maintained at 0.0016% and therefore did not exceed 0.01%, as recommended by OECD guidelines (OECD, 1992) .
Ibuprofen experiments
A (two-part) range-finder was conducted to assess the uptake of ibuprofen into fish blood plasma and to establish the water concentration(s) required to produce human therapeutic plasma concentrations (C max ) in fish. Fathead minnows (n ¼ 96; (wet) weight: 2.89 ± 0.53 g; (standard) length: 52.6 ± 4.04 mm) were first exposed, over 3e96 h, to SC (n ¼ 16) and nominal water concentrations of 100 and 500 mg ibuprofen/L (n ¼ 16 per concentration), using continuous flow-through conditions, and sampled (n ¼ 4) after 3, 24, 48 and 96 h. In the second part, fathead minnows were exposed, over 24e96 h, to SC (n ¼ 16) and nominal water concentrations of 270 and 370 mg ibuprofen/L, using continuous flowthrough conditions, and sampled (n ¼ 4) after 24, 48, 72 and 96 h.
Following the results of the range-finder, a suitable water (exposure) concentration was selected (one which was expected to produce fish plasma concentrations close to the C max ) in order to examine prostaglandin metabolite levels in fish. Using a larger sample size, fathead minnows (n ¼ 50; weight: 2.94 ± 0.80 g; length: 53.9 ± 4.27 mm) were exposed to SC (n ¼ 10) and the nominal water concentration of 350 mg ibuprofen/L (n ¼ 40) for 72 h, using continuous flow-through conditions, and then sampled.
In a third (smaller) experiment, designed to test the hypothesis that a low concentration of ibuprofen (one that would produce a fish plasma concentration well below the C max ) would not cause an effect on prostaglandin metabolite levels, fathead minnows (n ¼ 45; weight ¼ 2.74 ± 0.47 g; length ¼ 50.9 ± 4.03 mm) were exposed for 24e72 h to SC (n ¼ 9) and nominal water concentrations of 5 mg ibuprofen/L (n ¼ 18) or 350 mg ibuprofen/L (n ¼ 18), using static conditions. The 5 mg/L concentration was not expected to produce the effective plasma concentrations in fish and the 350 mg/L was included to test the repeatability of the results of the earlier experiment. Fish were sampled after 24, 48 and 72 h (SC, n ¼ 3; 5 mg/L, n ¼ 6; and 350 mg/L, n ¼ 6 at each time point). A static renewal design was used because it is much easier, uses lesser amounts of test chemical (ibuprofen) and is more cost-effective than it is to run a flow-through experiment. However, under ideal conditions, a flow-through would have been used.
Exposure conditions and water sampling
The dilution water was maintained at 25 ± 1 C, dissolved oxygen (DO) !80% air saturation and pH at 7.4 ± 1. For the continuous flow-through regime, dilution water flowed into glass mixing vessels at a rate of 250 mL/min, and also received the stock test solution (via a syringe) at a rate of 0.004 mL/min in order to achieve the desired concentration in the tank. Separate glass lines from each mixing vessel supplied to the tank produced eight tank volume changes per day, which subsequently went to waste. For the static experiment, ibuprofen stock solutions were administered directly into the tanks at the beginning of the exposure. Temperature, pH, DO, alkalinity, hardness and conductivity were measured twice during the exposures. Fish were subjected to a 16:8 h (light:dark) photoperiod, with a 20 min dawn/dusk transition period and were not fed during the exposures. The water concentration of ibuprofen was measured daily. Water samples (5 mL) were collected using a pipette from the center of each tank.
Fish blood plasma and gill sampling
After exposure, fish were anaesthetized with MS-222 (500 mg/L buffered with 1 M sodium bicarbonate to pH 7.4 and aerated) and humanely sacrificed according to UK Home Office procedures. Fish were immediately wet weighed (g) and the standard length measured (mm). Each fish was terminated by removal of the brain and the tail removed using a scalpel to collect blood into a heparinized micro-capillary tube (Fisher Scientific, Loughborough, UK). The tubes were sealed at one end and centrifuged (12,300 Â g, 4 min, 20 C) to separate the plasma, which was stored on ice prior to chemical analysis. The gill filaments were dissected, separated into two tubes, snap frozen in liquid nitrogen and stored at À80 C.
Chemical analysis of water and fish blood plasma
Ibuprofen concentrations were determined by reversed-phase Liquid Chromatography coupled with tandem Mass Spectrometry (LC-MS/MS) (see Appendix A). Initial chromatographic separation was carried out on a Dionex Ultimate 3000 instrument using a Gemini ® NX C18 column (50 Â 2.0 mm, 3 mm, Phenomenex, CA, USA) maintained at 50 C. The mobile phase consisted of 0.1% ammonia in water (eluent A) and 0.1% ammonia in methanol (eluent B), delivered at a flow rate of 500 mL/min. Ibuprofen was detected using an Ion Trap mass spectrometer (LTQ, Thermo Scientific, UK) with heated electrospray ionization. Data were acquired and processed using Xcalibur™ software (Thermo Scientific, UK). An internal standard, ibuprofen-d 3 (CAS No. 121662-14-4, !98% purity; Sigma-Aldrich, Dorset, UK) was used for the quantification of ibuprofen in plasma samples (spiked with 80 mg/L ibuprofen-d 3 ).
The samples were analyzed in duplicate.
Measurement of prostaglandin E metabolite (PGEM)
PGE 2 metabolites in the gills were measured using the Prostaglandin E Metabolite EIA Kit (Cayman Chemical Company, Ann Arbor, MI, USA). This kit converts unstable PGE 2 metabolites into a single, stable derivative (PGEM) that can be more easily quantified.
Briefly, frozen gill tissues (~20 mg) were lysed in 500 mL of homogenization buffer (0.1 M phosphate, pH 7.4, 1 mM EDTA containing 10 mM indomethacin to prevent ex vivo formation of prostaglandins) using a tissue lyser (Tissue Lyser II, QIAGEN, Manchester, UK) and centrifuged (8000 Â g, 10 min, 4 C). Up to 120 mL of the supernatant was removed for protein quantification. The remaining supernatant was incubated at À20 C for 60 min with 4 Â volumes of ice-cold acetone and centrifuged (400 Â g, 5 min, room temperature) to pellet the protein. The supernatant was transferred to a clean tube and the acetone was evaporated under nitrogen. The samples were re-suspended in enzymeimmunoassay buffer (0.1 M phosphate solution, pH 7.4, 0.1% bovine serum albumin, 0.4 M NaCl, 1 mM EDTA and 0.01% sodium azide). The PGEM standard solution (supplied in the kit) and samples were derivatized overnight at 37 C. The PGEM concentration in each sample (assayed in triplicate) was determined from an 8-point standard curve (standards assayed in duplicate; 0.39e50 pg/mL). The curve regression coefficient (r 2 ) was 0.9559.
The PGEM level was normalized against the sample protein concentration (mg/mL) determined using the QuantiPro™ bicinchoninic acid (BCA) assay (Sigma-Aldrich, Poole, UK), and is expressed as pg/mg protein. Wild-type mouse lung tissue obtained from Dr Pook's group, Brunel University London, was used as an additional positive control to ensure correct sample preparation.
Measurement of cyclooxygenase (ptgs) gene expression
Total RNA was isolated from gills (~20 mg) using the GenElute™ Mammalian Total RNA Miniprep kit (Sigma-Aldrich, Dorset, UK), treated with DNase I (Sigma-Aldrich, Dorset, UK) and reverse transcribed to cDNA using the iScript™ cDNA Synthesis Kit (BioRad Laboratories, Hertfordshire, UK). Nuclease-free water was added to the RNA template as a negative control. Quantitative realtime PCR (qPCR) was carried out using the ABI Prism ® 7900 HT realtime PCR instrument (Applied Biosystems, Life Technologies, Paisley, UK). The primers used to amplify ptgs genes were designed from template gene fragments that we previously isolated in the fathead minnow (Suppl. Table S1 ). Each 25 mL PCR reaction consisted of cDNA (50 ng/mL), 2Â QuantiFast SYBR Green mastermix (QIAGEN, Manchester, UK), forward and reverse primers (0.4 mM)
and nuclease-free water. The reactions were assayed in duplicate. Nuclease-free water was added to the no-template (negative) controls. Amplification was carried out using the following cycling conditions: initial denaturation at 95 C for 5 min, followed by 40 cycles at 95 C for 10 s and 60 C for 30 s. Melting curve analysis was used to check the specificity of the primers, and the amplicons were cloned and sequenced to confirm their identities. The mRNA levels of the ptgs genes were normalized against b-actin. Relative mRNA expression was calculated using the comparative (2 ÀDDCt ) method (Livak and Schmittgen, 2001 ). The amplification efficiency for each primer pair was determined by the slope of the Ct standard curve.
Measured vs. modeled fish plasma concentrations
Measured plasma ibuprofen concentrations, from fish exposed in the range-finder, were compared with plasma concentrations modeled using the Fish Plasma Model (FPM) (Huggett et al., 2003) , based on the non-kinetic bioconcentration model proposed by Fitzsimmons et al. (2001) . The fish plasma concentration was estimated using the Log K ow (3.80) reported by Brown et al. (2007) (Eq. 1). Many pharmaceuticals are amenable to ionization at different pH's and therefore use of the Log D (0.45 at pH 7.4, predicted using ACD/Labs, Toronto, ON, Canada) was also evaluated (Eq. 2). The fish plasma concentration was calculated using the measured water concentration over 96 h (Eq. 3). ½Fish Plasma ¼ ½Measured Water Â P blood:water (3)
Statistics
Results are presented as mean ± standard deviation (sd). Statistical analysis and graphs were created using GraphPad Prism 6 (GraphPad Software, Inc). Statistical significance was tested using unpaired t-tests or one-way ANOVA followed by a multiple comparison test (at p < 0.05, p < 0.001 or p < 0.0001). The relationship between plasma ibuprofen and PGEM level was examined using regression analysis.
Results
Measured water and blood plasma ibuprofen concentrations
In the range-finder, the mean measured water concentrations (over 96 h) were 105 ± 2, 278 ± 70, 409 ± 26 and 502 ± 56 mg ibuprofen/L, which were close to the nominal values (105, 103, 111 and 101%, respectively, of 100, 270, 370 and 500 mg ibuprofen/L) (Suppl . Table S2 ). Ibuprofen measurements in the water of SC tanks were below the Limit of Detection (LOD; 2.5 mg/L). Ibuprofen entered into fathead minnow blood plasma, but large interindividual variations were observed (Suppl. Table S3 ). The LOD for ibuprofen measurements in the plasma of SC fish was 30 mg/L.
The mean plasma ibuprofen concentrations (over 3e96 h) in fathead minnows exposed to nominal 100 and 500 mg/L were 657 ± 183 mg/L and 106,047 ± 71,291 mg/L, respectively. The mean plasma ibuprofen concentrations in fish exposed to nominal 270 and 370 mg/L (over 24e96 h) were 14,409 ± 22,084 mg/L and 40,540 ± 36,100 mg/L, respectively, closer to the human therapeutic plasma concentrations (C max ; 15,000e30,000 mg/L) (Schulz et al., 2012) . Therefore, the nominal water concentration of 350 mg/L was selected as a suitable exposure concentration for obtaining the C max in fish in the subsequent experiments.
In the second experiment, fish were exposed to the mean measured water concentration (over 24e72 h) of 370 (368 Table S2 ). This resulted in a mean plasma ibuprofen concentration of 8370 ± 5456 mg/L, which was 1.8-fold below the lowest C max (15,000 mg/L).
In the third experiment, fish were exposed to mean measured water concentrations (over 24e72 h) of 9 (±1) mg ibuprofen/L and 470 (473 ± 9) mg ibuprofen/L (181% and 135% of their respective nominal concentrations of 5 and 350 mg ibuprofen/L). This was a static water exposure and the discrepancy between the nominal and measured water concentrations was due to a dilution error. These water concentrations resulted in mean plasma ibuprofen concentrations of 67 ± 22 mg ibuprofen/L and 2680 ± 1605 mg ibuprofen/L, and were 224-fold and 5.6-fold below the lowest C max , respectively.
It is unclear why exposure to 470 mg ibuprofen/L resulted in a lower (mean) plasma ibuprofen concentration than exposure to 370 mg ibuprofen/L (2680 vs. 8370 mg ibuprofen/L). However, even though the mean plasma ibuprofen concentrations were different in the two experiments, there was some overlap as a consequence of the high fish-to-fish variability and unequal sample sizes (n ¼ 12 vs. n ¼ 40). The difference in the plasma concentrations could also be related to the static exposure regime utilized in the third experiment, as opposed to the flow through regime used in the previous experiments. However, the water (exposure) concentrations measured in the static experiment were generally stable (but higher than expected, due to a dilution error, as previously stated) 
PGEM levels in fathead minnow gill tissues
The mean PGEM level (14 ± 12.5 pg/mg) was significantly decreased (p ¼ < 0.0001) in the gills of fathead minnows exposed, for 72 h, to 370 mg ibuprofen/L (experiment 2), when compared to the SC (106 ± 80 pg/mg) (Fig. 1a) . To determine if the effects on PGEM could be replicated, and if an effect could be seen at a water concentration that was not expected to produce the effective fish plasma concentrations, fathead minnows were exposed to (measured) 9 mg ibuprofen/L (and 470 mg ibuprofen/L) over 24e72 h (experiment 3; data from exposed fish at 48 h not presented).
The mean PGEM level (884 ± 540 pg/mg) was not significantly different (p ¼ 0.30) in the gills of fish exposed to 9 mg ibuprofen/L, when compared to the SC (609 ± 635 pg/mg) (Fig. 1b) . The mean PGEM level (29 ± 30 pg/mg) was significantly decreased (p ¼ 0.005) in the gills of fish exposed to 470 mg ibuprofen/L, when compared to the SC, and 9 mg ibuprofen/L (p < 0.0001) (Fig. 1b) .
The PGEM levels were highly variable in the SCs (ranging between 10 and 248 pg/mg and 120e1680 pg/mg in the two experiments) and in the exposed groups (between 0.4-62 and 1.9e89 pg/ mg in the 370 and 470 mg ibuprofen/L groups, respectively). Fig. 1c demonstrates that the PGEM level was significantly decreased (p ¼ 0.001) between 24 and 72 h in fish exposed to 470 mg ibuprofen/L, indicating a time-dependent effect, similar to that which occurs in humans. There was no significant difference (p ¼ 0.9) in PGEM level between 24 and 72 h in fish exposed to 9 mg ibuprofen/L.
The relationship between plasma ibuprofen and PGEM levels
A dose-response between plasma ibuprofen and PGEM levels was seen between fish exposed to 9 mg ibuprofen/L (no mode-ofaction related response) and 370 and 470 mg ibuprofen/L (modeof-action related response observed) (Fig. 2) . However, there was no clear relationship between the plasma ibuprofen and the magnitude of the effect (i.e. amount of PGEM inhibition) in fish exposed to 370 and 470 mg ibuprofen/L (r 2 ¼ 0.01).
The PGEM levels in fish exposed to 9 mg ibuprofen/L were similar to the PGEM levels measured in the SC fish, when the mean plasma ibuprofen concentration (67 mg/L) was 224-fold below the lowest C max . Decreased PGEM levels were seen in fish exposed to 370 and 470 mg ibuprofen/L, when the mean plasma ibuprofen concentration was 1.8e5.6 fold below the lowest C max . The reduced PGEM levels were observed in fish with plasma ibuprofen concentrations spanning over 30-fold (from 710 to 22,000 mg ibuprofen/L). These results demonstrate that ibuprofen can inhibit PGEM levels over a range of plasma concentrations, including concentrations up to 21-fold below the lowest C max .
There was large inter-individual variation in plasma ibuprofen (30-fold, 710e22,000 mg/L) and PGEM levels (~50-fold, 2.4e118 pg/ mg). The PGEM levels were also highly variable in the SC fish (~170-fold, 10e1680 pg/mg).
Cyclooxygenase (ptgs) gene expression in gill tissues
We identified three isoforms of ptgs genes in the fathead minnow, a situation similar to that in zebrafish (Ishikawa et al., 2007) . In experiment 2, the mean expression of ptgs 1 was unchanged in gills of exposed fish (compared to SC fish), whereas the ptgs 2a and ptgs 2b genes trended towards up-regulation, with ptgs 2b being close to significance (p values ¼ 0.10, 0.12 and 0.07, respectively) (Suppl. Figure S1 ).
To establish if there was a dose-response between gene expression and drug plasma concentration, ptgs gene expression in gills and plasma ibuprofen in exposed fish was also examined; however, no correlation was observed (Suppl. Figure S2 ), nor between ptgs gene expression and PGEM levels in gills (Suppl. Figure S3 ).
Accuracy of the Fish Plasma Model (FPM)
The FPM, modeled using Log K ow , over-estimated the plasma ibuprofen concentration by 12-fold at 100 mg ibuprofen/L and under-estimated the plasma ibuprofen concentration by 3-fold at 500 mg ibuprofen/L (Fig. 3) . The FPM most accurately estimated the plasma ibuprofen concentration at 270 and 370 mg ibuprofen/L, the concentrations at which the C max was reached. The FPM severely under-estimated the plasma ibuprofen concentration in fish at all tested water concentrations when the Log D 7.4 was used.
Discussion
The aim of this study was to assess the validity of the readacross hypothesis, by examining the effects of ibuprofen on fish. We addressed the criteria of the read-across hypothesis, as outlined by Rand-Weaver et al. (2013) , and confirmed the water concentration(s) and blood plasma concentration(s) of ibuprofen, linked the exposure to a specific mode-of-action biological effect expected at the C max (by measuring PGEM, surrogate marker for PGE 2 ), and demonstrated that this effect was seen at plasma concentrations similar to (1.8-to 5.6-fold below) the lowest C max (15,000 mg/L). In humans, the therapeutic effects of ibuprofen (i.e. perceptible pain relief) have been reported at plasma ibuprofen levels of 6800e10,100 mg/L (20 min post 400 mg dosing), and maximal pain relief was confirmed at 30 min, when plasma levels were 14,800e18,900 mg/L (Mehlisch and Sykes, 2013) . These findings suggest that the on-set of therapeutic effects can occur at blood plasma concentrations below the stated C max (15,000e30,000 mg/L) (Schulz et al., 2012) , and may explain why the anticipated mode-ofeffect was observed in fish before the C max (peak plasma concentration) was reached.
A mode-of-action related effect on PGEM was observed in ibuprofen-exposed fish when the mean blood plasma concentration was 1.8-to 5.6-fold, but not 224-fold, below the lowest C max (15,000 mg/L). These findings provide evidence in support of the read-across hypothesis and demonstrate that pharmaceuticals can exert similar target-mediated pharmacological effects in fish as they do in humans, at similar blood plasma concentrations. Our findings are consistent with the mode-of-action relevant behavioral effects of sertraline and fluoxetine reported in fish at plasma concentrations similar to human therapeutic concentrations (Margiotta-Casaluci et al., 2014; Valenti et al., 2012) and the effects of the synthetic progestagen, levonorgestrel (Runnalls et al., 2015) . Collectively, these studies provide experimental evidence for the read-across hypothesis, identified as lacking by Rand-Weaver et al. (2013) . In fish exposed to the lowest tested concentration (9 mg ibuprofen/L), when the mean plasma ibuprofen concentration was 224-fold below the lowest C max , no mode-of-action effect on PGEM levels was seen.
The mode-of-action of ibuprofen is related to its non-specific inhibition of prostanoids, via the inhibition of the COX enzymes. Consistent with our findings, the effects of ibuprofen on PGE 2 levels have also been demonstrated in zebrafish (whole body homogenates or ovaries), following 7-d exposure to 21e506 mg/L (Morthorst et al., 2013) and in bluntnose minnows, following exposure to 50 mg/L and 100 mg/L ibuprofen, which resulted in a significant reduction in gill PGE 2 concentrations (Bhandari and Venables, 2011) . In the latter study, the lower (5 and 25 mg ibuprofen/L) concentrations tested did not result in a significant c. Fig. 1 . Prostaglandin E metabolite (PGEM) levels in the gills of fathead minnows exposed to solvent (SC) and ibuprofen. Fish were exposed to (a) SC (n ¼ 10) and 370 mg/L (n ¼ 40) for 72 h and (b) SC (n ¼ 9), 9 mg/L (n ¼ 12) and 470 mg/L (n ¼ 12) for 24, 48 (SC fish only) and 72 h (data combined). In (c), data from 9 and 470 mg/L are shown for 24 or 72 h (n ¼ 6 for each time point for each concentration). Each dot represents an individual fish within the treatment group, along with the mean ± sd.
* indicates significance level of p < 0.05, ** of p < 0.001 and *** of p < 0.0001. (Results presented are from experiments 2 and 3; and are displayed as such so that the data from every fish can be readily visualized). reduction in PGE 2 compared to the controls, similar to our findings.
The effect of ibuprofen on PGEM reduction in fish exposed to 470 mg ibuprofen/L was also more pronounced at 72 than 24 h. Such timedependency has not previously been reported in fish, but is in agreement with data from humans (Giagoudakis and Markantonis, 2005; Rane et al., 1978; Rome and Lands, 1975) .
Exposure to stressors can lead to pain and inflammation, resulting in a proliferated increase in prostanoids, primarily PGE 2 (Vane, 1971) . PGE 2, is chemically unstable and is rapidly converted in vivo to several PGE metabolites (13,14-dihydro-15-keto PGE 2 and 13,14-dihydro-15-keto PGA 2 ) (Ferreira and Vane, 1967) . For this reason, blood and other animal or human samples often contain very little intact PGE 2 . Therefore, in this study, the measurement of PGE metabolites (PGEM) was used to provide an estimate of the actual (parent) PGE 2 production. We investigated only the primary mammalian mode-of-action of ibuprofen, namely its ability to inhibit PGE 2 synthesis, and showed that ibuprofen acts via this mode-of-action in fish also. The biological functions of PGE 2 in fish are not well characterized, and the consequences of prostanoid inhibition in fish are presently unknown. However, prostanoids have been implicated in several "homeostatic" functions in fish, including reproduction (Fujimori et al., 2011; Gonçalves et al., 2014; Lister and Van Der Kraak, 2008; Sorbera et al., 2001 ) glucose metabolism (Busby, 2002) and immunity (G omez-Abell an and Sepulcre, 2016). Further work is necessary to investigate how NSAIDs affect fish physiology and until those consequences are known, it is not possible to develop a meaningful Adverse Outcomes Pathway for this group of pharmaceuticals.
In this study, we examined the effect of ibuprofen on the PGEM level in the gills, which we considered to be a suitable tissue for examining mode-of-action effects. In our preliminary work (data not shown) we also measured the PGEM level in liver and brain (the plasma was not used as it was required for chemical analysis). However, due to the limited amount of starting material and lower amounts of PGE 2 , the tissues had to be pooled (n ¼ 1), making any effect very difficult to ascertain. The PGEM level was easier to measure in gill tissue, in agreement with the results of others (Bhandari and Venables, 2011; Knight et al., 1995) who have reported a higher abundance, and the most consistent measurable levels of PGE 2 , in this tissue. However, as prostaglandin levels in one tissue (gills) do not represent global levels in fish, further studies should examine PGEM levels in blood plasma and other tissues.
The PGEM levels were highly variably in solvent control and ibuprofen-exposed fish. The variation in control groups suggests that factors other than drug exposure can also modulate PGEM production in "healthy" fish tissues. It is difficult to pinpoint the exact cause of such variation, since the controllable factors, 
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SC (n = 9) SC (n = 8) Fig. 2 . The relationship between plasma ibuprofen (mg/L) and gill Prostaglandin E metabolite (PGEM) levels (pg/mg) in fathead minnows. Fish were exposed for 72 hours to solvent (SC) and 9, 370 and 470 mg ibuprofen/L (n ¼ number of fish plasma samples analyzed; each dot represents an individual fish). Ibuprofen measurements in the plasma of SC fish were below the LOD (<30 mg/L). C max denotes the human therapeutic plasma concentrations (15,000e30,000 mg/L). The mean plasma ibuprofen level in fish exposed to 9 mg/L was 224-fold below the lowest C max (15,000 mg/L). The mean plasma ibuprofen level in fish exposed to 370 and 470 mg/L was 1.8 and 5.6-fold below the lowest C max . ( including sex (all male) and age (4e6 month), were the same, and the same handling and sampling procedures were used throughout. It has been suggested that changes in dietary fatty acids can result in extensive alteration in the profile of prostanoids in fish tissues (Norambuena et al., 2012) . However, in this study, the fish were not fed. We speculate that the variation observed in the control fish may be normal and represents the natural variation in a population of laboratory-bred fathead minnows. Further work is needed to gain an understanding of the "expected level" of the biological variation within a sample population. In order to reduce the uncertainty in the data, the sample size (n) could be increased, although it was reasonably high in the studies reported here.
There was a dose-response between plasma ibuprofen and PGEM levels between fish exposed 9 mg/L and 370 or 470 mg/L. margin between the plasma concentrations at which no PGEM inhibition was observed, and at which PGEM was significantly decreased. Further work is needed to ascertain the lowest (water) exposure concentration at which effects on PGEM would be seen (i.e. between 9 and 370 mg/L).
The large inter-individual variation in plasma ibuprofen concentrations has a major impact on attempts to relate effective drug plasma concentrations with target-mediated effects in fish, and can be identified as a limitation of the read-across approach. Further work is needed to identify the expected level of variation in drug plasma concentrations, particularly in fish exposed to the same concentration of a drug. Certainly, in humans, variability in drug responses between individuals is well recognized (Wood, 2001) , and therefore drugs exert their therapeutic effects over a range of concentrations (before adverse drug reactions occur) (Brune et al., 2010) . This variability is largely influenced by drug pharmacokinetics and pharmacodynamics (Derendorf et al., 2000; Reigner et al., 1997; Sheiner and Steimer, 2000) . For example, variations in plasma protein binding can affect the distribution of bound and free drug fractions in the body (Lin et al., 1987) and drug metabolism can be influenced by the presence of genetic polymorphisms (García-Martín et al., 2004) . Much less is known about pharmacokinetics and pharmacodynamics in fish; for instance, the drug plasma-protein binding kinetics (Owen et al., 2007) are nearly always unknown. It is possible that differential plasma-protein binding and/or drug distribution into other tissues may account for why reduced (gill) PGEM levels were seen in fish with plasma ibuprofen concentrations ranging over 30-fold. However, this is only speculative. Another possible explanation is saturation of the active sites of the COX protein following NSAID treatment, which has been observed in rat models (Satterwhite and Boudinot, 1991) . Ibuprofen is a weak, competitive non-selective inhibitor of the COX enzymes (Gierse et al., 1999) , and therefore after 72 h of continuous exposure, an increase in the plasma ibuprofen concentration beyond a certain level (i.e. when all available active sites have been occupied) possibly would have no further effect on PGEM inhibition.
It is possible to use the relationship between plasma concentrations in humans (the C max ), and in fish, in order to predict the likelihood for similar pharmacological responses (Huggett et al., 2003; Rand-Weaver et al., 2013; Schreiber et al., 2011) . The plasma concentrations modeled using FPM (using the Log K ow ) accurately mirrored the measured plasma concentration in fish exposed to 270 and 370 mg ibuprofen/L, and correctly predicted that the C max would be reached at these water concentrations. These findings are in agreement with other studies (Fick et al., 2010; Margiotta-Casaluci et al., 2014; Nallani et al., 2016; Valenti et al., 2012) that have used the FPM to accurately (within an order of magnitude) predict the plasma concentrations of human pharmaceuticals in fish. In contrast to our findings, a recent study found Log D 7.0 to be a better predictor of plasma bioconcentration in fish (Nallani et al., 2016) However, in that study, ibuprofen only weakly bioconcentrated (by 1.4-fold) into channel catfish plasma after 7-d exposure to measured water concentrations (314 ± 55 mg/L) (Nallani et al., 2011 ), whereas we show higher concentrations of ibuprofen accumulated in the plasma of fathead minnows. The FPM over (by 12-fold)-and under (by 3-fold)-estimated the plasma concentrations in fish exposed to 100 and 500 mg/L ibuprofen, respectively. It is not known why this was the case, however, potential sources of inaccuracy may arise from factors such as drug ionization, transporters, metabolism, excretion and/or plasma protein binding kinetics on drug uptake/plasma concentration. For example, the presence of steroid hormone binding globulins in teleost fish gills (Miguel-Queralt and Hammond, 2008) may increase the uptake rate of steroid pharmaceuticals above that predicted by the FPM. Despite the growing support for the use of the FPM, further experimental studies are still required in order to evaluate how well the concentration of a pharmaceutical in fish blood plasma can be theoretically modeled for a given water concentration.
The mammalian COX enzymes are encoded by the ptgs 1 and ptgs 2 genes. The additional ptgs 2 (2a and 2b) gene identified in the fathead minnow is likely a result of genome duplication in teleost fish (Havird et al., 2008) . The expression levels of all ptgs genes were not significantly different between control and exposed fish (Suppl. Figure S1 ), although there was a trend towards upregulation of the ptgs 2 genes (p ¼ 0.07 for ptgs 2b). This result is in agreement with those of other studies reporting little or no transcriptional change in ptgs gene expression in zebrafish exposed to ibuprofen (Ji et al., 2013; Morthorst et al., 2013) . In contrast, rainbow trout exposed for two weeks to 1.6e81.5 mg diclofenac/L (1.5e88% of the C max ) had global hepatic gene expression changes consistent with the mode-of-action of NSAIDs (Cuklev et al., 2011) . At plasma concentrations close to the C max , a number of genes functionally associated with inflammation and the immune response were differentially regulated in the liver, and the hepatic expression of the ptgs 1 and ptgs 2 genes was down-regulated. However, the lack of a concentration-related response raises questions about these results (Harris et al., 2014) . In our study, the gene expression levels were highly variable between individual fish, and no relationship between gill ptgs expression and plasma ibuprofen was observed, suggesting that this is not a suitable biomarker for ibuprofen exposure. Given the lack of knowledge of what influences gene expression and the sensitivity of this as an end-point, more research is required before robust conclusions can be reached regarding the relationship between the expression of the ptgs genes and their product, the COX enzyme.
Ibuprofen has been reported in UK surface waters and final effluents at typical mean concentrations of 74 ng/L (KasprzykHordern et al., 2009) and 2.48 mg/L (Gardner et al., 2012) , respectively. In this study, the 370 and 470 mg ibuprofen/L water concentrations produced plasma ibuprofen concentrations in fish closest to the C max and induced the anticipated mode-of-action related effect. Thus, this effect occurred at a water concentration between 190 and 6300-fold higher than the environmental concentration. However, in reality, pharmaceuticals exist as complex mixtures (Sumpter, 2009; Vasquez et al., 2014) , and there may be several prostanoid inhibitors present in the ng to mg/L range. Therefore, the potential for additive effects exist.
Conclusions
We demonstrate a mode-of-action related response on PGEM levels in fish exposed to ibuprofen, at blood plasma concentrations similar to those effective in humans. This study adds to an increasing body of research supporting the read-across hypothesis and FPM. However, we also highlight the importance of using large sample sizes, as large inter-individual variation was observed.
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